Article Text

Download PDFPDF
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications


In recent years, investigators have readdressed the complex issues involved in the classification of inflammatory bowel diseases. In 2003, a Working Party of investigators with an interest in the issues involved in disease subclassification was formed with the aim of summarising recent developments in disease classification and establishing an integrated clinical, molecular, and serological classification of inflammatory bowel disease. The results of the Working Party were reported at the 2005 Montreal World Congress of Gastroenterology. Here we highlight the key issues that have emerged from discussions of the Montreal Working Party and the relevance to clinical practice and research activities.

  • IBDU, inflammatory bowel disease, type unclassified
  • ASCA, anti-Saccharomyces cerevisiae antibody
  • ANCA, antineutrophil cytoplasmic autoantibody
  • inflammatory bowel disease
  • Crohn’s disease
  • ulcerative colitis
  • indeterminate colitis
  • classification

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.